Skip to main content
. 2005 Apr;43(4):1594–1599. doi: 10.1128/JCM.43.4.1594-1599.2005

TABLE 2.

Occurrence of acute exacerbation and HBeAg seroreversion after HBeAg seroclearance in different age groups

Age at HBeAg seroclearance (yr) No. of patients No. (%) with:
Acute exacerbation HBeAg seroreversion
≤20 12 1 (8.3) 1 (8.3)
20-30 60 13 (21.7) 3 (5.0)
30-40 71 20 (28.2) 11 (15.5)
40-50 45 16 (35.6) 7 (15.6)
>50 13 6 (46.2) 2 (15.4)